简体中文 | English
Long-acting fusion protein technology platform
Focus on unmet clinical needs
We sincerely invite and welcome established pharmaceutical companies, biotechnology firms, and investment institutions worldwide to explore potential business development and investment opportunities with us. Together, we can advance the development of innovative therapeutics.
We are open to various collaboration models, including licensing-out, co-development, and equity investment, and look forward to creating mutual value with global partners.
Contact us
描述
Email：kouqunhuan@jpyhfund.com